Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jeffrey Barroso"'
Autor:
Michael Fitzpatrick, Ruth Biehl, Sherrill J. Slichter, Gayle Teramura, Anna Yu, Jeffrey Barroso, Joan C. Pehta, Barbara A. Osborne, Esther Pellham
Publikováno v:
Transfusion. 58:2969-2977
BACKGROUND Current limitations of platelet shelf life to 5 days have led to an increasingly greater demand for hemostatic agents with greater longevity. The objective of this study was to evaluate the function of a lyophilized platelet-derived hemost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a0e32da2b6f0ad6e92f14b6c2b46f76
https://doi.org/10.1111/trf.14972
https://doi.org/10.1111/trf.14972
Autor:
Chakri Gavva, Paul Warner, Ryan A. Metcalf, Terry Gernsheimer, Monica B. Pagano, Jeffrey Barroso
Publikováno v:
Transfusion. 59(7)
BACKGROUND It is unknown how pooled platelets (PPs) compare to random apheresis platelets (RAPs) when HLA-selected platelets (PLTs) are unavailable for HLA-sensitized patients. The aim of this study was to compare patient responses to RAPs, HLA-selec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61bf97f25be9213f3aff3c9d1f29ed0
https://pubmed.ncbi.nlm.nih.gov/31032968
https://pubmed.ncbi.nlm.nih.gov/31032968
Autor:
Esther Pellham, Todd Christoffel, Irena Gettinger, Arianne Cundy, Shawn Lawrence Bailey, Sherrill J. Slichter, Jeffrey Barroso, Jill Corson, Vijyakrishna Gadi
Publikováno v:
Journal of Clinical Oncology. 35:e12521-e12521
e12521 Background: T-DM1 treatment results in Grade 3-4 thrombocytopenia in 8%-13% (1.4% with clinically significant bleeding). Prior in vitro studies reported T-DM1 inhibition of megakaryocyte maturation as the cause of decreased platelet production
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ccc221b3bc083a1b8ab4596db772a89
https://doi.org/10.1200/jco.2017.35.15_suppl.e12521
https://doi.org/10.1200/jco.2017.35.15_suppl.e12521